David Chen
Managing Director,
BFC Group
Ruyi He
Dr., Former Chief Scientist
China Food and Drug Administration (CFDA)
Dandan Dong
Managing Director
Vivo Capital
Dr. Yining Zhao
Co-Founder & Executive Chairman
Transcenta Holding
Michael Kaufman
Senior Vice President of Chemistry
Manufacturing and Controls, Mersana Therapeutics
Karen Liu
Founding Partner
3E Bioventures Capital
Jessica Li
Head of Asia Pacific Healthcare Investment Banking
Bank of America Merrill Lynch (BAML)
Michael Xue
Managing Director
Morningside Ventures
Xiaobo Lu
Sequoia Capital China
Astrid Maria Dahl
Executive Business Development Director
Oncology, AstraZeneca
Gayatri Varma
Director, Partnering & Strategy at MedImmune the early stage biologics R&D unit
Samuel Murphy
VP and Head of International Business Development
Salubris Pharmaceuticals
Lili Zheng
Partner in International Tax
Jonie Kondracki
Partner in Global Capital Markets Group
Cooley LLP
Christina Zhang
Partner-in-Charge, Shanghai Office
Cooley LLP
Armen Shanafelt
General Partner
Lilly Ventures
Founding Partner
Biotrack Capital
Yumin (Benjamin) Qiu
CFA, CMA, Partner
Dr. James Gage
Chief Scientific Officer
Charlie Kim
Partner and Co-Head of Global Capital Markets Group
Cooley LLP
David Ke
Executive Director
Healthcare Equity Capital Markets, J.P. Morgan
David P.W. Lau
Head of Hong Kong Investment Banking
J.P. Morgan
Katherine Xu
Partner and Co-Head of the Biopharmaceutical Equity Research Group
William Blair
Lila Hope
Partner in Global Life Sciences Partnering and Licensing Group
Cooley LLP